The validity and reliability of the Arabic version of the EQ-5D in atrial fibrillation patients in a conflict country: a study from Syria.
Atrial fibrillation
Conflict
EQ-5D
Quality of life
Syria
Journal
BMC cardiovascular disorders
ISSN: 1471-2261
Titre abrégé: BMC Cardiovasc Disord
Pays: England
ID NLM: 100968539
Informations de publication
Date de publication:
08 Oct 2024
08 Oct 2024
Historique:
received:
20
11
2023
accepted:
18
09
2024
medline:
9
10
2024
pubmed:
9
10
2024
entrez:
8
10
2024
Statut:
epublish
Résumé
The EQ-5D is one of the most commonly used tools to establish health-related quality of life (QoL). EQ-5D data in atrial fibrillation (AF) patients in the Middle East are lacking. This study aims to evaluate the reliability and validity of the Arabic version of the EQ-5D in AF inpatients in Syria. The study involved patients admitted to the emergency department of Tishreen's University Hospital in Latakia with AF as the primary diagnosis between the 1st of June 2021 and the 1st of June 2023. Arabic versions of the EQ-5D, EQ-VAS and SF36 questionnaires were administered to patients. Validation was done using convergent, discriminant, and known-groups validity, while reliability was conducted using EQ-5D retesting within 2-4 weeks. 432 participants were included in the study with a mean ± standard deviation of 63 ± 15. Males represented 242 (56%) of the participants. All hypotheses relating EQ-5D responses to external variables were satisfied. All three validation hypotheses demonstrated that the EQ-5D had the convergent, discriminant and known group validity to assess QoL in this cohort. The intraclass correlation coefficient (ICC) for test-retest reliability ranged between 0.74 and 0.88, while Cohen's κ ranged between 0.72 and 0.86. Cronbach's α value for internal consistency was 0.73. The Arabic version of EQ-5D was valid and reliable in measuring QoL in AF inpatients in Syria. This validation opens the door for more widespread use of the EQ-5D in Arabic-speaking regions, facilitating better-informed healthcare decisions and improving patient care strategies in Syria and other Middle Eastern countries.
Sections du résumé
BACKGROUND
BACKGROUND
The EQ-5D is one of the most commonly used tools to establish health-related quality of life (QoL). EQ-5D data in atrial fibrillation (AF) patients in the Middle East are lacking.
OBJECTIVES
OBJECTIVE
This study aims to evaluate the reliability and validity of the Arabic version of the EQ-5D in AF inpatients in Syria.
METHODS
METHODS
The study involved patients admitted to the emergency department of Tishreen's University Hospital in Latakia with AF as the primary diagnosis between the 1st of June 2021 and the 1st of June 2023. Arabic versions of the EQ-5D, EQ-VAS and SF36 questionnaires were administered to patients. Validation was done using convergent, discriminant, and known-groups validity, while reliability was conducted using EQ-5D retesting within 2-4 weeks.
RESULTS
RESULTS
432 participants were included in the study with a mean ± standard deviation of 63 ± 15. Males represented 242 (56%) of the participants. All hypotheses relating EQ-5D responses to external variables were satisfied. All three validation hypotheses demonstrated that the EQ-5D had the convergent, discriminant and known group validity to assess QoL in this cohort. The intraclass correlation coefficient (ICC) for test-retest reliability ranged between 0.74 and 0.88, while Cohen's κ ranged between 0.72 and 0.86. Cronbach's α value for internal consistency was 0.73.
CONCLUSION
CONCLUSIONS
The Arabic version of EQ-5D was valid and reliable in measuring QoL in AF inpatients in Syria. This validation opens the door for more widespread use of the EQ-5D in Arabic-speaking regions, facilitating better-informed healthcare decisions and improving patient care strategies in Syria and other Middle Eastern countries.
Identifiants
pubmed: 39379843
doi: 10.1186/s12872-024-04203-4
pii: 10.1186/s12872-024-04203-4
doi:
Types de publication
Journal Article
Validation Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
541Subventions
Organisme : British Heart Foundation
ID : RG/17/3/32,774
Pays : United Kingdom
Informations de copyright
© 2024. The Author(s).
Références
Ebrahim S. Clinical and public health perspectives and applications of health-related quality of life measurement. Soc Sci Med. 1995;41(10):1383–94.
doi: 10.1016/0277-9536(95)00116-O
pubmed: 8560306
Al Masri F, Müller M, Nebl J, Greupner T, Hahn A, Straka D. Quality of life among Syrian refugees in Germany: a cross-sectional pilot study. Archives Public Health. 2021;79:1–13.
doi: 10.1186/s13690-021-00745-7
Alwedyan S. Assessment of quality of life of Syrian refugees in Jordan: a questionnaire survey. Int J Sci Rep. 2022;8(12):356.
doi: 10.18203/issn.2454-2156.IntJSciRep20223032
Balestroni G, Bertolotti G. [EuroQol-5D (EQ-5D): an instrument for measuring quality of life]. Monaldi Arch Chest Dis. 2012;78(3):155–9.
pubmed: 23614330
Dyer MT, Goldsmith KA, Sharples LS, Buxton MJ. A review of health utilities using the EQ-5D in studies of cardiovascular disease. Health Qual Life Outcomes. 2010;8(1):1–12.
doi: 10.1186/1477-7525-8-13
Dudink EAMP, Erküner Ö, Berg J, Nieuwlaat R, de Vos CB, Weijs B, et al. The influence of progression of atrial fibrillation on quality of life: a report from the Euro Heart Survey. EP Europace. 2017;20(6):929–34.
doi: 10.1093/europace/eux217
Zare F, Ameri H, Madadizadeh F, Aghaei MR. Validity and reliability of the EQ-5D-3L (a generic preference-based instrument used for calculating quality-adjusted life-years) for patients with type 2 diabetes in Iran. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2021;15(1):319 – 24.
Moradi N, Poder TG, Safari H, Mojahedian MM, Ameri H. Psychometric properties of the EQ-5D-5L compared with EQ-5D-3L in cancer patients in Iran. Front Oncol. 2022;12:1052155.
doi: 10.3389/fonc.2022.1052155
pubmed: 36568223
pmcid: 9782428
Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Reviews Cardiol. 2014;11(11):639.
doi: 10.1038/nrcardio.2014.118
Al-Shamkhani W, Ayetey H, Lip GYH. Atrial fibrillation in the Middle East: unmapped, underdiagnosed, undertreated. Expert Rev Cardiovasc Ther. 2018;16(5):341–48.
Akiki D, El Hage S, Wakim E, Safi S, Assouad E, Salameh P. Atrial fibrillation in the Arab World: a bibliometric analysis of Research Activity from 2004 to 2019. J Cardiac Arrhythm. 2021;34(1):12–22.
doi: 10.24207/jca.v34i1.3430
Thrall G, Lane D, Carroll D, Lip GY. Quality of life in patients with atrial fibrillation: a systematic review. Am J Med. 2006;119(5):448. e1-. e19.
doi: 10.1016/j.amjmed.2005.10.057
Antoun I, Alkhayer A, Aboud Y, Alkhayer H, Kotb A, Alkhayer A, et al. COVID-19 inpatient treatments and outcomes during the conflict in Syria: an observational cohort study. IJID Reg. 2023;7:72–6.
doi: 10.1016/j.ijregi.2022.12.009
pubmed: 36593893
Antoun I, Alkhayer A, Kotb A, Barker J, Alkhayer A, Mahfoud Y, et al. The prevalence and prognostic value of diabetes and hypertension in patients treated for cholera during the ongoing Syrian conflict. Clin Infect Pract. 2024;23:100362.
doi: 10.1016/j.clinpr.2024.100362
pubmed: 39145146
pmcid: 11320765
Bekairy AM, Bustami RT, Almotairi M, Jarab A, Katheri AM, Aldebasi TM, et al. Validity and reliability of the arabic version of the the EuroQOL (EQ-5D). A study from Saudi Arabia. Int J Health Sci (Qassim). 2018;12(2):16–20.
pubmed: 29599689
Aburuz S, Bulatova N, Twalbeh M, Gazawi M. The validity and reliability of the arabic version of the EQ-5D: a study from Jordan. Ann Saudi Med. 2009;29(4):304–8.
doi: 10.4103/0256-4947.55313
pubmed: 19584581
pmcid: 2841459
Antoun I, Aljabal M, Alkhayer A, Mahfoud Y, Alkhayer A, Simon P et al. Atrial fibrillation inpatient management patterns and clinical outcomes during the conflict in Syria: an observational cohort study. Perfusion. 2024:2676591241259140.
Antoun I, Alkhayer A, Aljabal M, Mahfoud Y, Alkhayer A, Simon P, et al. Thirty-day unplanned readmissions following hospitalization for Atrial Fibrillation in a Tertiary Syrian Centre: a real-world Observational Cohort Study. Heart Rhythm O2. 2024.
Althemery A. Application of the EQ-5D in the Middle East: a systematic review focusing on patients living in the Kingdom of Saudi Arabia. J Multidisciplinary Healthc. 2021;14:1101–6.
Coons SJ, Alabdulmohsin SA, Draugalis JR, Hays RD. Reliability of an Arabic version of the RAND-36 Health Survey and its equivalence to the US-English version. Medical care. 1998:428 – 32.
El Osta N, Kanso F, Saad R, Khabbaz LR, Fakhouri J, El Osta L. Validation of the arabic version of the SF-36, generic questionnaire of quality of life related to health among the elderly in Lebanon. East Mediterr Health J. 2019;25(10):706–14.
pubmed: 31774136
McHorney CA, Ware Johne J. The MOS 36-Item short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31(3):247–63.
doi: 10.1097/00005650-199303000-00006
pubmed: 8450681
Kennedy I. Sample size determination in test-retest and Cronbach alpha reliability estimates. Br J Contemp Educ. 2022;2(1):17–29.
doi: 10.52589/BJCE-FY266HK9
Tavakol M, Dennick R. Making sense of Cronbach’s alpha. Int J Med Educ. 2011;2:53–5.
doi: 10.5116/ijme.4dfb.8dfd
pubmed: 28029643
pmcid: 4205511
Koo TK, Li MY. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J Chiropr Med. 2016;15(2):155–63.
doi: 10.1016/j.jcm.2016.02.012
pubmed: 27330520
pmcid: 4913118
Cohen J. Statistical power analysis for the behavioral sciences. Academic; 2013.
Nowels D, McGloin J, Westfall JM, Holcomb S. Validation of the EQ-5D quality of life instrument in patients after myocardial infarction. Qual Life Res. 2005;14:95–105.
doi: 10.1007/s11136-004-0614-4
pubmed: 15789944
Bano A, Rodondi N, Beer JH, Moschovitis G, Kobza R, Aeschbacher S, et al. Association of diabetes with atrial fibrillation phenotype and cardiac and neurological comorbidities: insights from the Swiss-AF study. J Am Heart Association. 2021;10(22):e021800.
doi: 10.1161/JAHA.121.021800
Moqeem K, Beeharry MW, Fang T, Lim KJM, Tsouklidis N. Factors influencing sex-related differences in the quality of life of patients with Atrial Fibrillation: a systematic review. Cureus. 2020;12(12):e12341.
pubmed: 33457142
pmcid: 7797428
Randolph TC, Simon DN, Thomas L, Allen LA, Fonarow GC, Gersh BJ, et al. Patient factors associated with quality of life in atrial fibrillation. Am Heart J. 2016;182:135–43.
doi: 10.1016/j.ahj.2016.08.003
pubmed: 27914493
pmcid: 5584577
Hernandez G, Garin O, Dima AL, Pont A, Martí Pastor M, Alonso J, et al. EuroQol (EQ-5D-5L) validity in assessing the quality of life in adults with Asthma: cross-sectional study. J Med Internet Res. 2019;21(1):e10178.
doi: 10.2196/10178
pubmed: 30672744
pmcid: 6364208
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomström-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): the Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373–498.
doi: 10.1093/eurheartj/ehaa612
pubmed: 32860505
Giannoulis K, Giannouli V. Subjective quality of life, religiousness, and spiritual experience in Greek Orthodox christians: data from healthy aging and patients with Cardiovascular Disease. Adv Exp Med Biol. 2020;1196:85–91.
doi: 10.1007/978-3-030-32637-1_8
pubmed: 32468309
Giannouli V, Giannoulis K. Better Understand to Better Predict Subjective Well-being among older greeks in COVID-19 era: depression, anxiety, attitudes towards eHealth, religiousness, spiritual experience, and Cognition. Adv Exp Med Biol. 2023;1425:359–64.
doi: 10.1007/978-3-031-31986-0_35
pubmed: 37581810